Copyright
©The Author(s) 2025.
World J Clin Cases. May 16, 2025; 13(14): 101981
Published online May 16, 2025. doi: 10.12998/wjcc.v13.i14.101981
Published online May 16, 2025. doi: 10.12998/wjcc.v13.i14.101981
Table 1 Classification of T lymphocytes in different periods
| T lymphocytes | February 2021 (before the appearance of the rash) | March 2021 (after the appearance of the rash) | April 2021 (after the development of the rash) |
| Total absolute number of T lymphocytes (per microliter) | 1860 | 1085 | 1406 |
| Absolute number of helper/induced T lymphocytes CD4+ (per microliter) | 1506 | 841 | 1012 |
| Absolute number of suppressor/cytotoxic T lymphocytes CD8+ (per microliter) | 333 | 242 | 364 |
| Percentage of helper/induced T lymphocytes | 60.93 | 56.07 | 47.36 |
| Suppressor/cytotoxic T lymphocyte percentage | 13.50 | 16.13 | 17.02 |
| Helper/suppressor T lymphocyte ratio CD4+/CD8+ | 4.51 | 3.48 | 2.78 |
- Citation: Mao XM, Wang WH. Vitiligo-like rash in a patient with lung cancer caused by sintilimab: A case report. World J Clin Cases 2025; 13(14): 101981
- URL: https://www.wjgnet.com/2307-8960/full/v13/i14/101981.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i14.101981